Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients.
about
Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumorsRegistered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulationsLiquid biopsy genotyping in lung cancer: ready for clinical utility?Interventional pulmonology approaches in the diagnosis and treatment of early stage non small cell lung cancerCirculating tumor DNA detection in lung cancer patients before and after surgeryLipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung CancerKRAS and the Reality of Personalized Medicine in Non-small Cell Lung Cancer.Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review.A genetic interaction analysis identifies cancer drivers that modify EGFR dependency.Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.Epidermal growth factor receptor T790M mutation as a prognostic factor in EGFR-mutant non-small cell lung cancer patients that acquired resistance to EGFR tyrosine kinase inhibitors.Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer.Personalized therapy for lung cancer: Striking a moving target
P2860
Q28077504-BBB10F72-205E-4F00-9EAC-E0CA5436B53DQ28603408-C25D7AEB-73B9-4BEA-BBEE-346DBD170D30Q33567037-42781AC6-BA6A-4765-9C86-4C000B013771Q35200670-F2A9CE40-6B42-4B01-B610-C64DAA5E8F73Q37264643-3A5B01E1-D01F-437F-A29F-5C65AAD11359Q37339704-3BE560D5-36F7-4BBC-B89D-0609B562519DQ37353957-DE85C275-2D86-47CD-9882-4B3DD99178ADQ38390205-6B2E22B2-C844-4E22-ABC4-F95DBF99CC1FQ38717620-147DF3F1-EE02-45F0-8978-774C323F155BQ41603225-9354FC83-33BB-450F-BAAF-0CA323FA845DQ47116265-703EF655-E006-463B-BB62-A5DF41DC6E98Q52904961-550683FB-D1DA-43CA-B6E4-0044972EA2C8Q58792324-68C856F5-142A-4902-907C-58FA2BB7EDE4
P2860
Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Tumor heterogeneity: evolution ...... all cell lung cancer patients.
@en
type
label
Tumor heterogeneity: evolution ...... all cell lung cancer patients.
@en
prefLabel
Tumor heterogeneity: evolution ...... all cell lung cancer patients.
@en
P2860
P1476
Tumor heterogeneity: evolution ...... all cell lung cancer patients.
@en
P2093
Jordi Remon
Margarita Majem
P2860
P304
P356
10.3978/J.ISSN.2218-6751.2013.03.09
P577
2013-06-01T00:00:00Z